RA Capital Management’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.93M | Hold |
|
|||||
|
2025
Q1 | $16.9M | Hold |
|
|||||
|
2024
Q4 | $50.2M | Hold |
|
|||||
|
2024
Q3 | $58.4M | Hold |
|
|||||
|
2024
Q2 | $48.4M | Buy |
|
|||||
|
2024
Q1 | $34.4M | Hold |
|
|||||
|
2023
Q4 | $23.7M | Hold |
|
|||||
|
2023
Q3 | $46M | Hold |
|
|||||
|
2023
Q2 | $62.3M | Hold |
|
|||||
|
2023
Q1 | $61M | Hold |
|
|||||
|
2022
Q4 | $55.4M | Buy |
|